MAXHEALTH
Max Healthcare Institute Limited (MAXHEALTH) Stock Analysis
Max Healthcare Institute Limited operates a chain of multi-specialty hospitals and clinics in India under the Max brand, offering tertiary care services. It earns from inpatient, outpatient, and international patient services. Growth comes from bed additions and occupancy improvements. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹946.30
+14.01% 1W | -17.10% 52W
Market Cap
92.1k CR
P/E Ratio
67
52W High
₹1185.4
52W Low
₹797
Div. Yield
0.22%
Beta
0.2
50 DMA
₹936.5
200 DMA
₹1010.4
Profit Margin
15.1%
Inst. Own.
57.1%
📉 CONSOLIDATING DOWN
📉 CONSOLIDATING DOWN
Fundamentals
Profit & Loss
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,363 | 1,335 | 1,423 | 1,543 | 1,707 | 1,868 | 1,910 | 2,028 | 2,135 | 2,068 | 2,143 | 2,366 | 2,569 |
| YoY Sales growth | +20% | +17% | +17% | +20% | +25% | +40% | +34% | +31% | +25% | +11% | +12% | +17% | +20% |
| Expenses | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,369 | 1,398 | 1,505 | 1,560 | 1,529 | 1,536 | 1,768 | 1,858 |
| Operating Profit | 387 | 386 | 382 | 387 | 451 | 499 | 512 | 523 | 575 | 538 | 606 | 598 | 711 |
| OPM % | 28% | 29% | 27% | 25% | 26% | 27% | 27% | 26% | 27% | 26% | 28% | 25% | 28% |
| Other Income | 45 | 46 | 45 | 35 | 41 | -40 | 47 | 37 | 33 | -3 | 48 | 41 | 41 |
| Interest | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 | 54 | 60 | 67 | 71 | 74 |
| Depreciation | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 | 108 | 111 | 123 | 132 | 138 |
| Profit before tax | 366 | 360 | 336 | 321 | 374 | 309 | 402 | 400 | 446 | 365 | 465 | 436 | 541 |
| Tax % | 24% | 20% | 25% | 26% | 25% | 23% | 21% | 23% | -10% | 17% | 26% | 26% | 23% |
| Net Profit | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 | 491 | 301 | 342 | 323 | 414 |
| EPS in Rs | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 | 3.09 | 3.52 | 3.31 | 4.26 |
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,608 | 1,729 | 1,691 | 1,059 | 2,508 | 3,937 | 4,563 | 5,406 | 7,028 | 8,373 | 9,146 |
| Sales growth | +8% | -2% | -37% | +137% | +57% | +16% | +18% | +30% | +19% | +15% | |
| Expenses | 1,467 | 1,616 | 1,535 | 965 | 2,101 | 2,986 | 3,322 | 3,913 | 5,180 | 6,131 | 6,691 |
| Operating Profit | 141 | 113 | 156 | 94 | 407 | 951 | 1,241 | 1,493 | 1,849 | 2,243 | 2,455 |
| OPM % | 9% | 7% | 9% | 9% | 16% | 24% | 27% | 28% | 26% | 27% | 27% |
| Other Income | 59 | 65 | 56 | 48 | -122 | 110 | 139 | 177 | 82 | 114 | 126 |
| Interest | 100 | 99 | 101 | 83 | 179 | 101 | 84 | 60 | 165 | 235 | 271 |
| Depreciation | 96 | 94 | 103 | 46 | 174 | 221 | 232 | 245 | 359 | 447 | 504 |
| Profit before tax | 5 | -15 | 8 | 13 | -69 | 739 | 1,064 | 1,365 | 1,406 | 1,676 | 1,806 |
| Tax % | -236% | 65% | 102% | -1% | 67% | 18% | -4% | 23% | 24% | 14% | |
| Net Profit | 16 | -25 | -0 | 59 | -138 | 605 | 1,104 | 1,058 | 1,076 | 1,442 | 1,381 |
| EPS in Rs | 0.29 | -0.47 | -0.06 | 1.10 | -1.42 | 6.24 | 11.37 | 10.88 | 11.07 | 14.82 | 14.18 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 14% | 14% | 13% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 22.0% | 27.0% | – |
| Profit CAGR | 10.0% | 60.0% | – |
Shareholding Pattern
Promoters23.74%
FIIs51.80%
DIIs20.03%
Public4.43%
Promoters23.72%
FIIs50.55%
DIIs21.20%
Public4.52%
Promoters23.71%
FIIs45.39%
DIIs26.32%
Public4.58%
Promoters23.71%
FIIs41.78%
DIIs29.95%
Public4.55%
Promoters23.71%
FIIs40.52%
DIIs31.01%
Public4.76%
Promoters23.77%
FIIs51.96%
DIIs19.36%
Public4.92%
Promoters23.75%
FIIs57.33%
DIIs14.96%
Public3.97%
Promoters23.74%
FIIs54.74%
DIIs17.59%
Public3.94%
Promoters23.71%
FIIs45.39%
DIIs26.32%
Public4.58%
Promoters23.71%
FIIs40.52%
DIIs31.01%
Public4.76%
MAXHEALTH
Holdings Analysis
Key strengths & risk signals
60
Overall
70
Fundamental
51
Technical
Risks (3)
OVERVALUED! PEG of 7.20 means expensive relative to growth rate.
WEAK YEAR! Stock declined 17.1% in the last year.
LOWER HALF! Trading at 38.4% of 52W range - weakness visible.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
MIXED POSITION! Current price (946.3) above 50-day but below 200-day.
NEUTRAL! RSI at 52.6 - balanced momentum.
Fundamental & Technical Analysis
60Overall
70Fundamental
51Technical
Fundamental Breakdown
Growth Quality
23/30
Revenue CAGR: 22.4% (EXCELLENT, 15/15). Profit CAGR: 9.3% (MODERATE, 8/15).
Profit Margin
6/10
GOOD EFFICIENCY! 15.1% profit margin - above average profitability.
PEG Valuation
0/10
OVERVALUED! PEG of 7.20 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.22% yield - little to no income.
Debt to Equity
8/10
LOW DEBT! D/E of 0.33 - strong balance sheet.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 4.45% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (936.5) is below 200-day average (1010.4) - negative signal.
Price Position
6/10
MIXED POSITION! Current price (946.3) above 50-day but below 200-day.
Trend Pattern
10/20
Current trend: CONSOLIDATING DOWN
52W Performance
2/10
WEAK YEAR! Stock declined 17.1% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 2,519,986 vs down days: 3,142,833. Ratio: 0.8x
RSI
3/5
NEUTRAL! RSI at 52.6 - balanced momentum.
52W Range
2/5
LOWER HALF! Trading at 38.4% of 52W range - weakness visible.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 14.0% (1 week), 9.9% (1 month), -6.2% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
MAXHEALTH
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q2FY272026-11-09 | Concall PDF | |
| Q1FY272026-08-05 | Concall PDF | |
| Q4FY262026-05-29 | Concall PDF | |
| Q3FY262026-02-12 | Concall PDF | |
| Q2FY262025-11-21 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MAXHEALTH | ₹946.30 | 67 | 15.1% | 22.4% | 9.3% | -17.1% | 60 | CONSOLIDATING DOWN | -15.6% | +28.5% | +20.3% | +8.6% |
| ASTERDM | ₹735.90 | 93.6 | 7.2% | 15.7% | -3.0% | +7.7% | 63 | BREAKOUT | – | +1,527.3% | – | +115.9% |
| APOLLOHOSP | ₹8,515.00 | 54.4 | 8.1% | 14.8% | 33.3% | +14.0% | 63 | CONSOLIDATING DOWN | – | +8.5% | +23.0% | +8.1% |
| FORTIS | ₹760.00 | 55.2 | 10.5% | 13.3% | 21.0% | -20.1% | 62 | APPROACHING SUPPORT | -3.0% | +17.3% | +17.3% | +7.5% |
| MEDANTA | ₹1,439.70 | 62.7 | 12.2% | 17.2% | 19.5% | +21.6% | 68 | APPROACHING SUPPORT | +39.3% | +39.1% | +33.6% | +12.6% |
| NH | ₹1,840.10 | 43.3 | 8.4% | 20.5% | 9.9% | +7.5% | 63 | BOUNCE FROM SUPPORT | +16.5% | +45.3% | +73.0% | +6.0% |
| KIMS | ₹727.30 | 139.3 | 4.6% | 21.3% | -10.5% | +5.0% | 55 | CONSOLIDATING DOWN | +12.1% | +80.7% | +39.9% | +14.0% |
| RAINBOW | ₹1,292.70 | 44.9 | 15.2% | 13.1% | 9.7% | -6.2% | 55 | CONSOLIDATING DOWN | +9.2% | +35.5% | +23.2% | +16.6% |
Data from TradeAlone · Updated daily
MAXHEALTH News
Max Healthcare Institute Limited (maxhealth) Q2 FY27: Revenue Rises 20% Yoy, PAT Up 10%2026-10-30Max Healthcare Institute Limited Inaugurates New 400 Beds Tower at Max Smart Super Speciality Hospital, Saket2026-09-03Max Healthcare Institute Ltd Q1 FY27: Revenue Rises 16% Yoy, Network Expands2026-08-13Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) moves up 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited Q4 FY26: Revenue Rises 10% Yoy, Network Operating Ebitda Up 8%2026-05-21
